Armis Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Armis Advisers's VRTX Position: Q2 2026 in Review
Armis Advisers increased its Vertex Pharmaceuticals (VRTX) stake by 5.5% in Q2 2026, buying an estimated $12K and bringing the position to 522 shares worth $276K. The position accounts for 0.03% of the portfolio, ranked #383.
Armis Advisers first reported a position in VRTX in Q4 2024 and has held it in 3 quarters since. The position peaked at $359K in Q4 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Armis Advisers held 522 shares of Vertex Pharmaceuticals worth $276K as of Q2 2026.
- Armis Advisers bought 27 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12K.
- Vertex Pharmaceuticals made up 0.03% of Armis Advisers's portfolio in Q2 2026, its #383 holding.
- Armis Advisers first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
- Armis Advisers's Vertex Pharmaceuticals position peaked at $359K in Q4 2024.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.